scholarly journals PHARMING EN ADOLESCENTES. CASO CLÍNICO

2021 ◽  
Keyword(s):  
Drug Abuse ◽  
Prescription Medication ◽  
Over The Counter ◽  
Palabras Clave ◽  
Consumo De Sustancias ◽  
Over The Counter Medicines

Objetivos. Presentación del concepto de pharming. Revisión de la bibliografía actual, epidemiología e implicaciones en el tratamiento. Discusión sobre el impacto en nuestra población de referencia y las posibles implicaciones en el diagnóstico y tratamiento. Material y métodos. Exposición de un caso de Pharming en adolescente. Revisión bibliográfica mediante búsqueda en PUBMED y EMBASE con las palabras clave: adolescents, drug abuse, over-the-counter medicines, prescription medication. Búsqueda en bases de datos epidemiológicas de nuestra región y de nuestro país. Resultados y conclusiones. El concepto de Pharming se refiere al uso de medicación con o sin receta, con una posología diferente a la recomendada y con un objetivo distinto al terapéutico, generalmente recreativo. El consumo suele realizarse acompañando a otros tóxicos. Se presenta el caso de un adolescente de 17 años con uso de levomepromazina y alcohol en contexto recreativo. Fue atendido en Urgencias hospitalarias en dos ocasiones por este motivo. Las primeras descripciones hablan del uso de fármacos sin receta, antitusígenos generalmente, pero en los últimos años se ha registrado el abuso de casi cualquier tipo de medicación, desde benzodiacepinas a estimulantes y medicación para el trastorno por déficit de atención con hiperactividad. Este efecto parece estar relacionado con un aumento de este tipo de prescripciones en la población y una mayor facilidad para el acceso a esta medicación. La importancia de este fenómeno radica en que puede suponer la puerta de entrada a otro tipo de consumos y también en la dificultad para su detección y tratamiento, por la facilidad de acceso a la sustancia. El conocimiento de este fenómeno por parte de los médicos que tratan a adolescentes, tanto en consultas como en Urgencias, y de los padres es necesario para prevenir la morbilidad y mortalidad asociadas al consumo de sustancias.

Television Advertising of Nonprescription Medicines: The Case for the Defendant

1976 ◽  
Vol 6 (1) ◽  
pp. 85-90 ◽  
Author(s):  
James D. Cope
Keyword(s):  
Drug Abuse ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Television Advertising ◽  
Over The Counter ◽  
Ongoing Work ◽  
Otc Medicines ◽  
Over The Counter Medicines

When critics raised suggestions that a link existed between drug abuse and the advertising of over-the-counter (OTC) medicines, the Proprietary Association commissioned independent studies to determine if there were truth to the allegations. “The weight of the evidence refutes the alleged relationship between advertising and drug abuse,” concludes the author of this paper. He also outlines the ongoing work of the OTC Review Panels, commissioned by the Food and Drug Administration, to evaluate ingredients in all over-the-counter medicines available to American consumers.

Legal Regulation of Treatment for Depression

2017 ◽  
Author(s):  
Hugh Series
Keyword(s):  
Legal Regulation ◽  
Mental Capacity ◽  
Medicinal Products ◽  
Over The Counter ◽  
Controlled Drugs ◽  
Treatment Of Depression ◽  
Mental Capacity Act 2005 ◽  
Incapacitated Patients ◽  
Mental Capacity Act ◽  
Over The Counter Medicines

This chapter reviews the legal regulation of treatment of depression as it exists in England and Wales, where medicinal products are regulated largely by the Medicines Act 1988 and the Misuse of Drugs Act 1971. The Medicines Act divides medicinal products into pharmacy only medicines, which can only be purchased under the supervision of a pharmacist, over-the-counter medicines, and prescription only medicines. The Misuse of Drugs Act is concerned with controlled drugs. These are divided into three classes according to their perceived degree of harmfulness. This chapter considers treatment with valid consent and two pieces of legislation that govern people who are sufficiently ill and need to be admitted to hospital: the Mental Health Act 1983 (MHA) and the Mental Capacity Act 2005 (MCA). It also discusses treatment of mentally incapacitated patients and the issue of liberty regarding the admission of a compliant but incapacitated patient to hospital. Finally, it looks at three types of non-medical prescribing in England, issued by independent prescribers, supplementary prescribers, and community practitioners.

373 Historical Use of Substances for Insomnia Impacts Current Beliefs about Hypnotic Medications

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A148-A149
Author(s):  
Jessica Dietch ◽  
Norah Simpson ◽  
Joshua Tutek ◽  
Isabelle Tully ◽  
Elizabeth Rangel ◽  
...  
Keyword(s):  
Prescription Medication ◽  
Stepped Care ◽  
Future Research ◽  
Prescription Medications ◽  
Over The Counter ◽  
Multiple Treatment ◽  
History Of ◽  
Study Participants ◽  
Beliefs About Medications ◽  
The Impact

Abstract Introduction The purpose of the current study was to examine the relationship between current beliefs about hypnotic medications and historical use of prescription hypnotic medications or non-prescription substances for sleep (i.e., over the counter [OTC] medications, alcohol, and cannabis). Methods Participants were 142 middle age and older adults with insomnia (M age = 62.9 [SD = 8.1]; 71.1% female) enrolled in the RCT of the Effectiveness of Stepped-Care Sleep Therapy In General Practice (RESTING) study. Participants reported on history of substances they have tried for insomnia and completed the Beliefs about Medications Questionnaire-Specific with two subscales assessing beliefs about 1) the necessity for hypnotics, and 2) concerns about potential adverse consequences of hypnotics. Participants were grouped based on whether they had used no substances for sleep (No Subs, 11.6%), only prescription medications (Rx Only, 9.5%), only non-prescription substances (NonRx Only, 26.6%), or both prescription and non-prescription substances (Both, 52.3%). Results Sixty-one percent of the sample had used prescription medication for sleep and 79% had used non-prescription substances (74% OTC medication, 23% alcohol, 34% cannabis). The greater number of historical substances endorsed, the stronger the beliefs about necessity of hypnotics, F(1,140)=23.3, p<.001, but not about concerns. Substance groups differed significantly on necessity beliefs, F(3,1)=10.68, p<.001; post-hocs revealed the Both group had stronger beliefs than the No and NonRx Only groups. Substance groups also differed significantly on the concerns subscale, F(3,1)=6.68, p<.001; post-hocs revealed the NonRx Only group had stronger harm beliefs than the other three groups. Conclusion The majority of the sample had used both prescription and non-prescription substances to treat insomnia. Historical use of substances for treating insomnia was associated with current beliefs about hypnotics. Individuals who had used both prescription and non-prescription substances for sleep in the past had stronger beliefs about needing hypnotics to sleep at present, which may reflect a pattern of multiple treatment failures. Individuals who had only tried non-prescription substances for sleep may have specifically sought alternative substances due to concerns about using hypnotics. Future research should seek to understand the impact of treatment history on engagement in and benefit from non-medication-based treatment for insomnia. Support (if any) 1R01AG057500; 2T32MH019938-26A1

Factors that influence Italian consumers’ understanding of over-the-counter medicines and risk perception

2012 ◽  
Vol 87 (3) ◽  
pp. 395-401 ◽  
Author(s):  
Andrea Calamusa ◽  
Alessandra Di Marzio ◽  
Renza Cristofani ◽  
Paola Arrighetti ◽  
Vincenzo Santaniello ◽  
...  
Keyword(s):  
Risk Perception ◽  
Over The Counter ◽  
Over The Counter Medicines

Use of over-the-counter medicines for young children in Australia

2010 ◽  
Vol 46 (1-2) ◽  
pp. 5-9 ◽  
Author(s):  
Misel Trajanovska ◽  
Elizabeth Manias ◽  
Noel Cranswick ◽  
Linda Johnston
Keyword(s):  
Young Children ◽  
Over The Counter ◽  
Over The Counter Medicines

scholarly journals How the Lifestyle Leaders View and Manage Medications

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 611-612
Author(s):  
Taylor Patskanick ◽  
Julie Miller
Keyword(s):  
Side Effects ◽  
Medication Management ◽  
Healthcare Providers ◽  
Prescription Medication ◽  
The Internet ◽  
Prescription Medications ◽  
Over The Counter ◽  
Attitudes And Behaviors ◽  
The Past ◽  
Drug Companies

Abstract Medication management is an ongoing consideration for adults ages 85 and older, their caregivers, and healthcare providers. When asked about their attitudes and behaviors regarding medication management, over 73% of the Lifestyle Leaders reported taking 3+ prescription medications daily and managing their own medication regimes. 61.9% of participants had taken over-the-counter, non-prescription medication for pain over the past five years. When asked why some participants didn’t currently take prescription medications to manage pain, the most frequently-reported responses were: “I don’t feel that my pain warrants a prescription medication,” (19%, n=8), “I don’t want to deal with the side effects,” and “I don’t trust drug companies,” (9.5%, n=4, respectively). The Lifestyle Leaders reported they would be most likely to go to the internet (over their local pharmacist) to ask for advice about their medication(s). Meanwhile, 39% of Lifestyle Leaders would trust a robot to manage their medication(s) for them.

scholarly journals Proper Drug Disposal: Studying a Solution to Household Prescription and Over-the- Counter Drug Abuse

2016 ◽  
Vol 02 (02) ◽  
Author(s):  
Gustavo Kinrys ◽  
Alexandra K Gold ◽  
Andrew A Nierenberg
Keyword(s):  
Drug Abuse ◽  
Over The Counter

Abuse of Combination Stimulants

1986 ◽  
Vol 7 (8) ◽  
pp. 234-254
Keyword(s):  
Weight Loss ◽  
Ventricular Tachycardia ◽  
Drug Abuse ◽  
Cerebral Hemorrhage ◽  
Ventricular Arrhythmias ◽  
Over The Counter ◽  
Adrenergic Effects

Over-the-counter preparations for weight loss have become very popular in this country during the last several years. Most of these preparations are combination stimulants containing phenylpropanolamine, ephedrine, and caffeine. They are widely advertised, readily available, and have become a major item for adolescent drug abuse. All of these substances have potent and direct adrenergic effects and catecholamine-releasing actions. Hypertension, cerebral hemorrhage, and psychosis have all been associated with use of phenylpropanolamine. Caffeine has been reported to cause ventricular arrhythmias, including ventricular tachycardia. There is a possibility that simultaneous ingestion of all of these drugs could increase the risk of toxicity from each. Propanolol is the treatment of choice for toxicity manifested by moderate symptomatic hypertension plus atrial or ventricular arrhythmias.

Sign in / Sign up

Export Citation Format

Share Document